Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.
Jason Brandt; Barnett Shpritz; Ann Marie Codori; Russell Margolis; Adam Rosenblatt (Profiled Authors: Russell Margolis; Ann-Marie Codori; Adam Rosenblatt; Jason Brandt)
Baltimore Huntington's Disease Research Center, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, MD, USA. jbrandt@jhmi.edu
Journal of the International Neuropsychological Society : JINS 2002;8(7):918-24.
A triplet repeat (CAG) expansion mutation in the huntingtin gene on chromosome 4 is responsible for Huntington's disease (HD). Presymptomatic genetic testing for this mutation has identified clinically normal persons who are virtually certain to develop this dementing illness if they live a normal lifespan. The present study sought to determine whether these "mutation-positive" persons have impairments in cognitive functioning. Seventy-five mutation-positive persons did not differ from 128 mutation-negative persons on tests selected for their sensitivity to early-stage HD. Interestingly, however, those with the mutation viewed themselves as more likely to develop HD than did those without the mutation. Among mutation-positive subjects, having a longer CAG repeat mutation was likewise not associated with cognitive impairment. However, being closer to estimated disease onset (a product of repeat length and parent's age at onset) was associated with selected cognitive impairments. When viewed in light of previous studies showing atrophy of the caudate nucleus and putamen in mutation-carriers who are close to onset but not those far from onset, these results suggest that subtle changes in brain and behavior may be detected shortly before subjects with the HD mutation develop sufficient signs and symptoms for diagnosis. Conceptual and methodological problems associated with the search for presymptomatic cognitive and behavioral indicators of dementing illness are discussed.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2011Julie C Stout; Jane S Paulsen; Sarah Queller; Andrea C Solomon; Kathryn B Whitlock; J Colin Campbell; Noelle Carlozzi; Kevin Duff; Leigh J Beglinger; Douglas R Langbehn; et al.
Neurocognitive signs in prodromal Huntington disease.
Neuropsychology 2011;25(1):1-14. -
2.
2008J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; et al.
Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
Journal of neurology, neurosurgery, and psychiatry 2008;79(8):874-80. -
3.
2006Julianna Ward; Jeannie-Marie Sheppard; Barnett Shpritz; Russell L Margolis; Adam Rosenblatt; Jason Brandt
A four-year prospective study of cognitive functioning in Huntington's disease.
Journal of the International Neuropsychological Society : JINS 2006;12(4):445-54.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
327









-
136









-
241









-
81









-
121









-
21










